Skin reaction to adalimumab
β
W. Beuthien; H.-U. Mellinghoff; J. von Kempis
π
Article
π
2004
π
John Wiley and Sons
π
English
β 91 KB
## Abstract The tumor necrosis factor Ξ± (TNFΞ±) inhibitors etanercept and infliximab have shown good clinical results in the treatment of rheumatoid arthritis and other autoimmune disorders. With these novel fusion proteins, immuneβmediated side effects, among them various cutaneous reactions, have